Management of the insulin resistance syndrome
- Cite this article as:
- Desouza, C., Gilling, L. & Fonseca, V. Curr Diab Rep (2001) 1: 140. doi:10.1007/s11892-001-0026-6
- 42 Downloads
The insulin resistance syndrome (IRS) is a common disorder, which has important clinical implications. It is a cluster of cardiovascular risk factors that include obesity, hypertension, dyslipidemia, glucose intolerance, and type 2 diabetes mellitus. Lifestyle modifications and insulin sensitizers are among the several therapeutic strategies available for the treatment of the IRS. Optimal treatment will not only improve glycemic control, but may also significantly lower cardiovascular disease.